Endo appoints new R&D chief
This article was originally published in Scrip
Executive Summary
Endo – a speciality healthcare company developing medicines for pain management, urology, oncology and endocrinology indications – has named Dr Susan Hall chief scientific officer and global head of R&D and quality, effective 10 March 2014. Prior to joining the Dublin, Ireland-based firm Dr Hall was senior vice-president and global head of R&D at Valeant Pharmaceuticals. Furthermore, she has also held various R&D leadership positions at GlaxoSmithKline.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.